Home › Cardiovascular Disease › Washington › Tacoma
Cardiovascular Disease clinical trials in Tacoma, WA
4 studies for Cardiovascular Disease are looking for participants at sites in and around Tacoma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ELEVATE-HFpEF Clinical Study
Recruiting
- Saint Joseph Medical Center (Tacoma WA), Tacoma
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Universal Research Group, LLC, Tacoma
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- MultiCare Institute for Research and Innovation, Tacoma
- MultiCare Institute for Research and Innovation, Puyallup · 8 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Tacoma
- Research Site, Puyallup · 8 mi away
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Tacoma
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer18 studies
- Ulcerative Colitis15 studies
- Multiple Myeloma13 studies
- Prostate Cancer11 studies
- Crohn's Disease11 studies
- Metastatic Cancer9 studies
- Colorectal Cancer9 studies
- Melanoma7 studies
- Ovarian Cancer7 studies
- Cancer (all types)6 studies
- Pancreatic Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.